Occlusal dysesthesia: A qualitative systematic review of the epidemiology, aetiology and management

Journal of Oral Rehabilitation

Volumn 39, Issue 8, 2012, Pages 630-638

  Hara, E S ^a   Matsuka, Y ^a   Minakuchi, H ^a   Clark, G T ^b   Kuboki, Takuo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Neuroplasticity; Occlusal dysesthesia; Occlusal hyperawareness; Phantom bite; Proprioception dysfunction; Somatoform disorder

Indexed keywords

ADULT; FEMALE; HUMAN; MALE; MALOCCLUSION; MIDDLE AGED; PARESTHESIA; PSYCHOLOGICAL ASPECT; REVIEW; SOMATOFORM DISORDER;

ADULT; FEMALE; HUMANS; MALE; MALOCCLUSION; MIDDLE AGED; PARESTHESIA; SOMATOFORM DISORDERS;

EID: 84863528017     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2012.02300.x     Document Type: Review

References (30)

1. Marbach JJ. Phantom bite. Am J Orthod. 1976;70:190-199.
2. Marbach JJ. Phantom bite syndrome. Am J Psychiatry. 1978;135:476-479.
3. Marbach JJ, Varoscak JR, Blank RT, Lund P "Phantom bite": classification and treatment. J Prosthet Dent. 1983;49:556-559.
4. Marbach JJ. Psychosocial factors for failure to adapt to dental prostheses. Dent Clin North Am. 1985;29:215-233.
5. Greene PA. Proprioception Dysfunction vs phantom bite: diagnostic considerations reported. TM Diary. 1994;2:16-17.
6. Marbach JJ. Orofacial phantom pain: theory and phenomenology. J Am Dent Assoc. 1996;127:221-229.
7. Clark G, Simmons M. Occlusal dysesthesia and temporomandibular disorders: is there a link? Alpha Omegan. 2003;96:33-39.
8. Jagger RG, Korszun A. Phantom bite revisited. Br Dent J. 2004;197:241-243.
9. Baba K, Aridome K, Haketa T, Kino K, Ohyama T. Sensory perceptive and discriminative abilities of patients with occlusal dysesthesia. Nihon Hotetsu Shika Gakkai Zasshi. 2005;49:599-607.
10. Clark GT, Minakuchi H, Lotaif AC. Orofacial pain and sensory disorders in the elderly. Dent Clin North Am. 2005;49:343-362.
11. Toyofuku A, Kikuta T. Treatment of phantom bite syndrome with milnacipran - a case series. Neuropsychiatr Dis Treat. 2006;2:387-390.
12. Reeves JL II, Merrill RL. Diagnostic and treatment challenges in occlusal dysesthesia. J Calif Dent Assoc. 2007;35:198-207.
13. Medicine OCfE-b. Oxford Centre for Evidence-based Medicine - Levels of Evidence. Oxford Universtiy; 2009.
14. Locker D, Slade G. Prevalence of symptoms associated with temporomandibular disorders in a Canadian population. Community Dent Oral Epidemiol. 1988;16:310-313.
15. Tay DK, Soh G, Tan LS, Tan KL. The prevalence of unilateral mastication in a non-patient population: a pilot study. Ann Acad Med Singapore. 1989;18:556-559.
16. Zulqarnain BJ, Khan N, Khattab S. Self-reported symptoms of temporomandibular dysfunction in a female university student population in Saudi Arabia. J Oral Rehabil. 1998;25:946-953.
17. Sonnesen L, Svensson P. Temporomandibular disorders and psychological status in adult patients with a deep bite. Eur J Orthod. 2008;30:621-629.
18. Wong MTH. Phantom bite in a Chinese lady. J Hong Kong Med Assoc. 1991;43:105-107.
19. Nishiyama N, Kamiya K. Chewing-related hypofrontality in psychiatric disorders complaining occlusal dysesthesia. IADR General meeting, Toronto; 2008.
20. Tsukiyama AY, Ichiki R, Koyano K. Physical and psychosocial characteristics of Occlusal Dysesthesia. IADR General Meeting Toronto; 2008.
21. Munro A. Monosymptomatic hypochondriacal psychosis. Br J Psychiatry Suppl. 1988;2:37-40.
22. Munro A. Monosymptomatic hypochondriacal psychosis. Br J Hosp Med. 1980;24:34.
23. American Psychiatric Association. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. Washington, DC: American pyschiatric association; 1994.
24. World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd edn. Geneva: World Health Organization; 2005.
25. Melzack R. Pain: past, present and future. Can J Exp Psychol. 1993;47:615-629.
26. Gluck MR, Thomas RG, Davis KL, Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry. 2002;159:1165-1173.
27. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20:201-225.
28. Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron. 2004;44:161-179.
29. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiat Res. 1999;33:513-521.
30. Rammsayer TH. Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. Learn Mem. 2001;8:20-25.